Search
Close this search box.

Q4 2023 update: private equity deals in medical devices in the UK

In value terms, private equity deal activity in the UK increased by 3254% in Q4 2023 compared with the previous quarter’s total of $32.8m and rose by 8792% as compared to Q4 2022. Related deal volume remained flat in Q4 2023 versus the previous quarter and was 33% lower than in Q4 2022.

The top-ranked financial advisors supporting these private equity deals in the UK in Q4 2023 were Barclays; Benchmark International; DSW Capital with 1, 1, 1 deals respectively.

The top-ranked legal advisorss supporting these private equity deals in the UK Q4 2023 were Allen & Overy; Birketts; Gunner Cooke with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In 2023 – Thematic Intelligence, buy the report here.

This content was updated on 8 January 2024

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.